Lung diseases are a major global health concern. Many conditions begin silently with subtle signs. Early detection of symptoms like breathlessness, persistent cough, and fatigue is vital. This allows ...
For some patients with the most common type of lung cancer, known as lung adenocarcinoma, there's new hope. In a new study ...
Alecensa reduced death risk by 22% compared to Xalkori in advanced ALK-positive NSCLC, with a median OS of 81.1 months versus 54.2 months. The study was not powered for OS, resulting in ...
The FDA approved taletrectinib (Ibtrozi)-- a next-generation oral ROS1 tyrosine kinase inhibitor (TKI) -- for the treatment of adults with locally advanced or metastatic ROS1-positive non-small cell ...
Happiness is more than a mood; it’s “a state of well-being that encompasses living a good life, one with a sense of meaning and deep contentment.” It is a personal commitment to be optimistic even ...
There are many treatment options for lung cancer, but the right one for you will depend on many factors including the type of lung cancer you have. Non-small-cell lung cancer (NSCLC) is the most ...
United Therapeutics is making headway in unlocking a new lung disease market for its drug Tyvaso (treprostinil) with a pivotal phase 3 win in idiopathic pulmonary fibrosis (IPF). United’s Teton-2 ...
A kindergarten teacher who survived a mass shooting in a Bronx park that left one dead and three others wounded may spend the rest of her life with a grisly memento of the bloody carnage — a bullet ...
After an extremely tough couple of months, former UFC star Ben Askren thankfully seems to be on the road to recovery. A few months ago, it was shockingly announced that former UFC star Ben Askren was ...
Nuvalent Inc. (NASDAQ:NUVL) is one of the best high short interest stocks with huge upside potential. On June 24, Nuvalent announced positive pivotal data from its global ARROS-1 Phase 1/2 clinical ...
Company has requested End of Phase 2 Meeting and Breakthrough Therapy Designation (BTD) based upon the positive FDA Meeting feedback OS Therapies (NYSE-A: OSTX) (“OS Therapies” or “the Company”), a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback